03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Vaxigrip* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | UPO |
Distributor | UPO |
Laboratory | Sanofi Pasteur |
Responsible Party | Sanofi Pasteur SA |
Origin | France |
Manufacturer | Sanofi Pasteur SA |
Origin | France |
ATC | J07BB01 |
Vaxigrip* :
Vaxigrip* :
Vaxigrip* :
Vaxigrip* :
Vaxigrip* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Vaxigrip* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Allergic reaction | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Very Common |
Cephalea | Very Common |
Chills | Common |
Convulsion | Not known |
Diarrhoea (Diarrhea) | Uncommon |
Dizziness | Uncommon |
Dyspnoea (dyspnea) | Not known |
Encephalomyelitis | Not known |
Eruption | Rare |
Erythema | Rare |
Fever | Common |
Flu-like syndrome | Uncommon |
Generalized erythema | Rare |
Guillain-Barre syndrome | Not known |
Henoch-Schönlein purpura | Not known |
Hypoesthesia | Rare |
Injection site discomfort | Uncommon |
Injection site Ecchymosis | Common |
Injection site erythema | Very Common |
Injection site induration | Very Common |
Injection site oedema | Very Common |
Injection site pain | Very Common |
Injection site pruritus | Very Common |
Injection site redness | Very Common |
Injection site swelling | Very Common |
Injection site tenderness | Very Common |
Injection site warmth | Uncommon |
Lymphadenopathy | Uncommon |
Malaise | Very Common |
Myalgia | Very Common |
Nausea | Uncommon |
Neuralgia | Rare |
Neuritis | Not known |
Neurological disorders | Not known |
Paraesthesia (paresthesia) | Rare |
Pruritus | Rare |
Pruritus generalized | Rare |
Radiculitis brachial | Rare |
Renal disorder | Not known |
Shock | Not known |
Somnolence | Uncommon |
Sweating increased (Excessive sweating) (Hyperhydrosis) | Common |
Swelling face | Rare |
Thrombocytopenia (Thrombopenia) | Not known |
Urticaria | Rare |
Vasculitides | Not known |
Vaxigrip* :
NB : Products With Same Indication |
Different Units By MoH Code
Vaxigrip* MoH 402 :
Form | Suspension for injection |
Packaging | Pre-filled Syringe |
Package Size | 1 x0.5ml |
Strength | 15µg |
Storage Condition | 2-8°C Do not freeze |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 28502 |
Submission date | 01/01/1993 |
Registration Year | 1993 |
Archived Date | 2019 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File